Tata Memorial Centre clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-20
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-23 | NCT07891923 Less Doses of Daratumumab Are Adequate to Achieve Response in Newly Diagnosed Multiple… | Phase 2 | Recruiting |
Active trials by phase
| Phase 1/2 | 1 | |
| Phase 2 | 12 | |
| Phase 2/3 | 2 | |
| Phase 3 | 5 |
Not charted: 25 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 16
Glioma (10) · Breast Cancer (3) · Colorectal Cancer (3) · Prostate Cancer (3) · Bladder Cancer (2) · Cholangiocarcinoma (2) · Glioblastoma (2) · Leukemia (2) · Acute Lymphoblastic Leukemia (ALL) (1) · Cervical Cancer (1)
Get alerts when Tata Memorial Centre's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.